Macrogenics (MGNX) Preferred Shares (2012 - 2013)
Macrogenics' (MGNX) quarterly Preferred Shares came in at $714012.0 in Q3 2013, up 394.26% on a QoQ basis from $144462.0 in Q4 2012.
Macrogenics (MGNX) Preferred Shares (2012 - 2013) Analysis & Trends
Macrogenics (MGNX) has 2 years of Preferred Shares data on file, last reported at $714012.0 in Q3 2013.
- On a quarterly basis, Preferred Shares changed N/A year-over-year to $714012.0 in Q3 2013; TTM through Sep 2013 was $714012.0, a N/A change from a year earlier, with the FY2012 full-year figure at $144462.0, changed N/A from the prior year.
- Preferred Shares for Q3 2013 stood at $714012.0, up from $144462.0 in the prior quarter.
- Over the last five years, Preferred Shares for MGNX reached as high as $714012.0 in Q3 2013 and fell as low as $144462.0 in Q4 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Macrogenics | 254.43 Mn | 187.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2013 | 714,012.00 |
| Dec 31, 2012 | 144,462.00 |